WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Ownership - Who owns Viridian Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viridian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2026-05-111,176,470$17.00
$20.00MBuy
Thomas W. BeethamChief Operating Officer2026-03-033,138$29.32
$92.01kSell
Thomas W. BeethamChief Operating Officer2026-03-033,048$30.19
$92.02kSell
Jennifer TousignantChief Legal Officer2026-03-031,675$30.19
$50.57kSell
Jennifer TousignantChief Legal Officer2026-03-031,724$29.32
$50.55kSell
Thomas W. BeethamChief Operating Officer2026-03-033,138$29.32
$92.01kSell
Seth HarmonChief Financial Officer2026-03-032,091$29.32
$61.31kSell
Seth HarmonChief Financial Officer2026-03-032,091$29.32
$61.31kSell
Seth HarmonChief Financial Officer2026-03-032,031$30.19
$61.32kSell
Stephen F. MahoneyPresident and CEO2026-03-037,627$29.32
$223.62kSell

1 of 2

VRDN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRDN insiders and whales buy or sell their stock.

VRDN Shareholders

What type of owners hold Viridian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.57%15,379,377$353.26MInstitution
Fairmount Funds Management LLC8.41%9,531,779$218.94MInsider
Blackrock Inc6.91%7,831,475$179.89MInstitution
Bellevue Group Ag5.94%6,726,144$154.50MInstitution
Logos Global Master Fund LP5.30%6,000,000$137.82MInsider
State Street Corp4.12%4,672,885$107.34MInstitution
Vanguard Capital Management LLC3.68%4,167,201$95.72MInstitution
Fairmount Funds Management LLC3.46%3,914,458$89.92MInstitution
Venrock Adviser LLC3.43%3,882,709$89.19MInstitution
Price T Rowe Associates Inc2.83%3,206,035$73.64MInstitution

1 of 3

VRDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRDN75.63%24.37%Net Buying
AMLX67.16%32.84%Net SellingNet Selling
NKTR52.04%47.96%Net SellingNet Selling
RARE84.29%15.71%Net SellingNet Selling
TRVI43.91%56.09%Net Buying
View Top Biotech Stocks

Viridian Therapeutics Stock Ownership FAQ

Who owns Viridian Therapeutics?

Viridian Therapeutics (NASDAQ: VRDN) is owned by 99.19% institutional shareholders, 31.97% Viridian Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Viridian Therapeutics shareholder, owning 9.53M shares representing 8.41% of the company. Fairmount Funds Management LLC's Viridian Therapeutics shares are currently valued at $218.09M.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.